Sarepta Therapeutics Inc
Sarepta Therapeutics's GHG Emissions Data Preview
In 2023, Sarepta Therapeutics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Sarepta Therapeutics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data. | 0000000 |
Verified Sources Behind Sarepta Therapeutics’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sarepta Therapeutics’s data sources below and access millions more through our Disclosure Search.
Insights into Sarepta Therapeutics's Operational Emissions
In 2023, the total operational greenhouse gas (GHG) emissions of Sarepta Therapeutics amounted to 8,428 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Sarepta Therapeutics increased by 12.52%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
Sarepta Therapeutics's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Sarepta Therapeutics's Scope 1 emissions?
In 2023, the total Scope 1 emissions of Sarepta Therapeutics were 3,428 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2022), Sarepta Therapeutics's Scope 1 emissions increased by 26.92%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
What are Sarepta Therapeutics's Scope 2 emissions?
In 2023, Sarepta Therapeutics reported Scope 2 greenhouse gas (GHG) emissions of 5,000 tCO₂e without specifying the calculation method. a
Has Sarepta Therapeutics reduced its Scope 2 emissions over time?
Compared to the previous year (2022), Sarepta Therapeutics's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Sarepta Therapeutics 's emissions have plateaued with no significant change in its energy consumption footprint. a
What methodology does Sarepta Therapeutics use for Scope 2 reporting?
In 2023, Sarepta Therapeutics reported its Scope 2 emissions using an unspecified methodology. a
Sarepta Therapeutics's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Sarepta Therapeutics’s GHG Emissions Intensity Compared to Industry Peers
In 2023, Sarepta Therapeutics reported Scope 1 greenhouse gas (GHG) emissions of 3,428 tCO₂e and total revenues of USD 1,243 millions. This translates into an emissions intensity of 2.76 tCO₂e per millions USD. a
Sarepta Therapeutics's Scope 1 Emissions Intensity Compared to Peers
How does Sarepta Therapeutics's GHG emissions intensity compare to its peers?
In 2023, Sarepta Therapeutics reported a Scope 1 emissions intensity of 2.76 tCO₂e per millions USD. Compared to the peer group median of 2.64 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a
Where does Sarepta Therapeutics rank on GHG emissions intensity within its industry?
In 2023, Sarepta Therapeutics ranked 12 out of 21 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Sarepta Therapeutics is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a